Both in Pharmaceuticals
USANA Health Sciences vs Korro Bio
Over the past year USNA returned −30.3% and KRRO returned −50.9%; their daily moves had a correlation of 0.05.
USNA −30.3% KRRO −50.9%Growth of $1, one year, split-adjusted
| Metric | USNA | KRRO |
|---|---|---|
| Price | $14.33 | $16.62 |
| Market cap | $264.8M | $244.7M |
| Today | −3.63% | +4.79% |
| 1 month | −3.4% | +70.3% |
| 6 months | −28.4% | +24.6% |
| Year to date | −27.0% | +107.5% |
| 1 year | −32.6% | −54.9% |
| Revenue growth (YoY) | −5.3% | −100.0% |
| Gross margin | 78.3% | — |
| Net margin | −9.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 102.7× |
| Net cash | $168.6M | $115.0M |
| Dividend yield | — | — |
| Volatility (60d) | 34.7% | 96.1% |
| Short % of float | 7.2% | 14.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).